Bruce Feinberg, DO; Brian Kiss, MD; and Michael Kolodziej, MD, discuss challenges and opportunities for better utilizing palliative care to reduce cost and improve quality of care in oncology.
Dr Feinberg notes that currently, only half of appropriate patients receive hospice care, and the average length of stay is 7 days. Dr Feinberg asks Drs Kiss and Kolodziej to discuss ways to improve the utilization of palliative care.
Current guidelines suggest that doctors initiate discussions about palliative care with patients and patients’ loved ones when cancer has advanced or patients begin to have intractable pain, Dr Kiss explains. For this reason, palliative care is often not discussed until late in a patient’s disease course. Dr Kiss suggests that initiating conversations about palliative care early-on is key.
Dr Kolodziej describes the importance of adequate education and training in palliative care in oncology. He explains that discussing palliative care or end-of-life care with patients is among the most difficult of tasks for an oncologist. He notes that historically, there hasn’t been enough focus on educating and training oncologists regarding palliative care.
Another challenge, the result of a lack of palliative care training, is that many terms related to palliative care are misunderstood, adds Dr Kolodziej. Oncologists, he says, need to understand how to differentiate between palliative care, end-of-life care, and hospice care.
Balancing Cost and Quality in Oncology: A Value-Based Care Perspective
January 30th 2025Travis Brewer, vice president of payer and public health strategy/relations at Texas Oncology, shared that value-based oncology care can achieve both cost efficiency and high-quality outcomes through integrated multidisciplinary teams, flexible payment models, and targeted treatment approaches.
Read More
Unlocking Access: Exploring Mental Health Care Among Medicaid Managed Care Enrollees
January 23rd 2025On this episode of Managed Care Cast, we speak with the author of a study published in the January 2025 issue of The American Journal of Managed Care® to examine the association between quantitative network adequacy standards and mental health care access among adult Medicaid enrollees.
Listen
How FcRn Blockade Targets Myasthenia Gravis Autoantibodies
January 29th 2025In part 2 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the challenge inherent in treating adolescents who have the myasthenia gravis and how nipocalimab works via FcRn blockade to reduce the circulating autoantibodies that drive myasthenia gravis.
Read More